Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and safely disrupting hyperactive autonomic nerves that drive underlying inflammation. Their proprietary NEUROMARK® technology enables physicians to precisely target and disrupt multiple underlying nerve branches to alleviate Chronic Rhinitis symptoms, improving patient quality of life. The company is headquartered in Galway, Ireland, with a US office in Boston, MA, and has demonstrated significant clinical improvements in treating chronic rhinitis, positioning itself as a leader in this niche medical device market.